TAVLESSE

Medicinal product

(Invented) name

TAVLESSE

Active substance (s)

Fostamatinibas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX09, Fostamatinib

Marketing authorisation holder

Instituto Grifols, S.A., Ispanija

Date of authorisation

2020-01-09

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Fostamatinibas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103086	89187	1089187	buteliukas	N60		Receptinis	EU/1/19/1405/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-01-09	Registruotas